Finally, in 2006, a report including 69 HCC patients who accepted liver transplantation from 1998 to 2001 pointed out that patients with a high CD4 +/CD8+TIL ratio had low recurrence risk after treatment (53). Here, CD8A is linked to hepatocellular carcinoma.